| 发明名称 | Method of enhancing diabetes resolution | ||
| 摘要 | Disclosed are compositions and methods for increasing diabetes resolution in a diabetic patient having undergone gastric restrictive surgery, entailing use of active agent that produces an incretin-like effect in the patient. | ||
| 申请公布号 | US9522175(B2) | 申请公布日期 | 2016.12.20 |
| 申请号 | US201414243473 | 申请日期 | 2014.04.02 |
| 申请人 | Hamilton Scientific, Ltd. | 发明人 | Rothkopf Michael |
| 分类号 | A61K38/26;A61K31/40;A61K31/403;A61K31/4985;A61K38/22;A61K31/00 | 主分类号 | A61K38/26 |
| 代理机构 | Burns & Levinson LLP | 代理人 | Burns & Levinson LLP ;Foley Shawn P. |
| 主权项 | 1. A method for treating a type II diabetic patient having undergone gastric restrictive surgery that does not involve a bypass to achieve diabetes resolution, comprising administering to the patient an agent that produces an incretin-like effect in the patient in an amount effective to achieve diabetes resolution, wherein the agent comprises a DPP-IV inhibitor, and wherein said treating increases likelihood of achieving the diabetes resolution relative to a patient having undergone the gastric restrictive surgery but who has not had said treating. | ||
| 地址 | Cedar Grove NJ US | ||